Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Device could ‘capture’ exhaled anaesthetic from surgeries
21 per cent of the carbon emissions from an orthopaedic procedure is volatile anaesthetics.
The technology aims to tackle the gas’ impact on global warming.

A research project from the University of Nottingham has explored how a volatile gas capture device could reduce the impact of anaesthetic gases on the environment.

Scientists estimate that 21 per cent of carbon emissions from a canine orthopaedic procedure is the result of volatile anaesthetics.

The study sought to investigate the efficiency of a volatile gas capture device in collecting gases from anaesthetised dogs and cats. The technology could be used in future to capture the gases, and then reprocess and reuse them as anaesthetic drugs.

It is hoped this could lead to a move from a linear (take-make-waste) economy to a circular (reuse-repair-recycle) economy.

Researchers were able to demonstrate a 65 per cent capture of isoflurane. It prevented an average release of 3.75kgCO2e for each 20-minute period of the study – the equivalent of 14 miles driven in a car.

However, they did identify that the device’s capture was dependent on multiple factors, including the patient’s blood pressure.

Kate White, who led the study, said: “Reducing the carbon footprint associated with anaesthesia and surgery, in humans or animals, is an important issue, and one way we can do this is to capture the waste gases to prevent environmental damage.  

“My team have been evaluating the capture of isoflurane, sevoflurane and desflurane using SageTech's technology in dogs, cats, horses, ruminants and even zoo animals and teaching the veterinary students at the University of Nottingham about the concept.  

“The technology in combination with interventions such as reducing single use items and low flow anaesthesia offers significant potential as we transition to a low carbon world.”

The study has been published in the British Journal of Anaesthesia.

Image © Shutterstock 

Become a member or log in to add this story to your CPD history

Voting opens for BEVA Council

News Story 1
 Eligible members of BEVA will be able to vote for their Council team until Monday, 17 August 2026. Members will have received an election email on 17 July.

There are five candidates standing for four available places on Council. They are:

  • Alexandre Triguino
  • Angela Jones
  • Beth Bryant
  • Holly Rees
  • Hugh Somerville
Full profiles for each candidate can be found on the BEVA website

Click here for more...
News Shorts
Government releases latest bluetongue statistics

APHA has confirmed the number of bluetongue cases that have been logged in the UK since 1 July 2026.

The total number of BTV-3 cases, as of 6 August, is 187. This includes 183 cases in England and four cases in Wales.

There have been no recorded cases in Scotland and Northern Ireland.

The location of premises in Great Britain where at least one animal has tested positive by PCR for BTV-3, BTV-8 or BTV-12 is available on the bluetongue case map. All livestock keepers in Great Britain are urged to familiarise themselves with nation-specific bluetongue control policies.

Bluetongue virus is a notifiable disease. It is a legal requirement that any suspicions, even if livestock has been vaccinated, are reported immediately.